Novel targets detected by next generation sequencing among triple refractory patients can be clinically targetable

CENGİZ SEVAL G., KUZU I., Yüksel S., YILMAZ H., Yavuz G., KAYGUSUZ G., ...Daha Fazla

19th International Myeloma Society Annual Meeting, 25 Ağustos 2022 identifier

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Ankara Üniversitesi Adresli: Evet